1. Home
  2. GEOS vs LSBPW Comparison

GEOS vs LSBPW Comparison

Compare GEOS & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEOS
  • LSBPW
  • Stock Information
  • Founded
  • GEOS 1980
  • LSBPW N/A
  • Country
  • GEOS United States
  • LSBPW China
  • Employees
  • GEOS N/A
  • LSBPW 758
  • Industry
  • GEOS Industrial Machinery/Components
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEOS Industrials
  • LSBPW Health Care
  • Exchange
  • GEOS Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • GEOS N/A
  • LSBPW N/A
  • IPO Year
  • GEOS 1997
  • LSBPW N/A
  • Fundamental
  • Price
  • GEOS $9.74
  • LSBPW $0.06
  • Analyst Decision
  • GEOS
  • LSBPW
  • Analyst Count
  • GEOS 0
  • LSBPW 0
  • Target Price
  • GEOS N/A
  • LSBPW N/A
  • AVG Volume (30 Days)
  • GEOS 43.7K
  • LSBPW N/A
  • Earning Date
  • GEOS 02-05-2025
  • LSBPW N/A
  • Dividend Yield
  • GEOS N/A
  • LSBPW N/A
  • EPS Growth
  • GEOS N/A
  • LSBPW N/A
  • EPS
  • GEOS N/A
  • LSBPW N/A
  • Revenue
  • GEOS $135,598,000.00
  • LSBPW N/A
  • Revenue This Year
  • GEOS N/A
  • LSBPW N/A
  • Revenue Next Year
  • GEOS N/A
  • LSBPW N/A
  • P/E Ratio
  • GEOS N/A
  • LSBPW N/A
  • Revenue Growth
  • GEOS 8.91
  • LSBPW N/A
  • 52 Week Low
  • GEOS $8.09
  • LSBPW N/A
  • 52 Week High
  • GEOS $17.09
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • GEOS 39.37
  • LSBPW N/A
  • Support Level
  • GEOS $9.76
  • LSBPW N/A
  • Resistance Level
  • GEOS $10.28
  • LSBPW N/A
  • Average True Range (ATR)
  • GEOS 0.33
  • LSBPW 0.00
  • MACD
  • GEOS 0.04
  • LSBPW 0.00
  • Stochastic Oscillator
  • GEOS 14.12
  • LSBPW 0.00

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: